Procyon Advisors’s Celularity Inc CELUW Stock Holding History

Procyon Advisors’s Portfolio CELUW Stock Details CELUW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52	Hold	11,500	–	–	﹤0.01%	588
2026 Q1	$114	Hold	11,500	–	–	﹤0.01%	584
2025 Q4	$187	Hold	11,500	–	–	﹤0.01%	561
2025 Q3	$404	Hold	11,500	–	–	﹤0.01%	507
2025 Q2	$509	Hold	11,500	–	–	﹤0.01%	465
2025 Q1	$460	Buy	+11,500	New	+$620	﹤0.01%	595

Procyon Advisors's CELUW Position: Q2 2026 in Review

Procyon Advisors held its Celularity Inc (CELUW) position steady in Q2 2026 at 11,500 shares worth $52. The position accounts for ﹤0.01% of the portfolio, ranked #588.

Procyon Advisors first reported a position in CELUW in Q1 2025 and has held it in 6 quarters since. The position peaked at $509 in Q2 2025. 1 fund tracked by Wall St. Rank holds CELUW as of Q2 2026.

Procyon Advisors held 11,500 shares of Celularity Inc worth $52 as of Q2 2026.
Procyon Advisors left its Celularity Inc share count unchanged in Q2 2026.
Celularity Inc made up ﹤0.01% of Procyon Advisors's portfolio in Q2 2026, its #588 holding.
Procyon Advisors first reported a position in Celularity Inc in Q1 2025 and has held it in 6 quarters since.
Procyon Advisors's Celularity Inc position peaked at $509 in Q2 2025.
1 fund tracked by Wall St. Rank held Celularity Inc as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.